HK Stock MarketDetailed Quotes
03933 UNITED LAB
- 10.220
- -0.540-5.02%
Market Closed Nov 8 16:08 CST
18.57BMarket Cap5.83P/E (TTM)
10.900High10.140Low8.82MVolume10.800Open10.760Pre Close91.55MTurnover0.49%Turnover Ratio6.23P/E (Static)1.82BShares11.74052wk High1.25P/B18.57BFloat Cap5.90552wk Low0.62Dividend TTM1.82BShs Float12.624Historical High0.570Dividend LFY7.06%Amplitude-0.240Historical Low10.382Avg Price2000Lot Size6.02%Div YieldTTM5.58%Div Yield LFY
UNITED LAB Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.90%7.18B | 21.22%13.74B | 33.28%6.91B | 16.81%11.33B | 9.81%5.18B | 10.61%9.7B | 9.63%4.72B | 4.53%8.77B | 5.25%4.3B | 11.74%8.39B |
| Operating income | 3.90%7.18B | 21.22%13.74B | 33.28%6.91B | 16.81%11.33B | 9.81%5.18B | 10.61%9.7B | 9.63%4.72B | 4.53%8.77B | 5.25%4.3B | 11.74%8.39B |
| Cost of sales | -3.74%-3.83B | -16.34%-7.41B | -26.14%-3.69B | -15.89%-6.37B | -11.62%-2.93B | -10.59%-5.49B | -4.65%-2.62B | -4.09%-4.97B | -5.81%-2.51B | -7.02%-4.77B |
| Operating expenses | -3.74%-3.83B | -16.34%-7.41B | -26.14%-3.69B | -15.89%-6.37B | -11.62%-2.93B | -10.59%-5.49B | -4.65%-2.62B | -4.09%-4.97B | -5.81%-2.51B | -7.02%-4.77B |
| Gross profit | 4.08%3.34B | 27.49%6.33B | 42.56%3.21B | 18.00%4.97B | 7.54%2.25B | 10.64%4.21B | 16.57%2.1B | 5.11%3.81B | 4.47%1.8B | 18.65%3.62B |
| Selling expenses | 27.52%-706.65M | 4.13%-1.59B | -20.99%-974.91M | -1.77%-1.66B | -6.95%-805.74M | -10.08%-1.63B | -5.92%-753.35M | -0.42%-1.48B | 6.73%-711.25M | -24.58%-1.48B |
| Administrative expenses | 7.00%-354.05M | -12.30%-789.86M | -10.39%-380.69M | -0.72%-703.35M | -2.48%-344.85M | 5.89%-698.34M | -2.79%-336.5M | -0.18%-742M | 9.12%-327.38M | -14.51%-740.65M |
| Research and development expenses | -31.92%-446.8M | ---- | -39.60%-338.68M | ---- | -19.41%-242.61M | ---- | -24.83%-203.17M | ---- | -37.28%-162.76M | ---- |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200.45M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.89%-97.61M |
| -Changes in the fair value of investment property | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.89%-97.61M |
| Impairment and provision | -454.61%-38.76M | -83.26%1.96M | 43.55%-6.99M | 103.95%11.72M | 88.28%-12.38M | -349.93%-296.56M | -5,210.76%-105.58M | -761.03%-65.91M | 80.03%-1.99M | -463.49%-7.66M |
| -Other impairment is provision | -454.61%-38.76M | -83.26%1.96M | 43.55%-6.99M | 103.95%11.72M | 88.28%-12.38M | -349.93%-296.56M | -5,210.76%-105.58M | -761.03%-65.91M | 80.03%-1.99M | -463.49%-7.66M |
| Special items of operating profit | -7.02%128.95M | -3.02%-542.24M | 37,586.96%138.69M | -64.58%-526.37M | -99.36%368K | -134.79%-319.82M | -30.12%57.29M | 48.70%-136.22M | 78.38%81.98M | 14.93%-265.54M |
| Operating profit | 16.74%1.93B | 63.31%3.41B | 94.49%1.65B | 65.38%2.09B | 12.48%848.76M | -8.37%1.26B | 11.52%754.57M | 11.81%1.38B | 60.21%676.6M | 51.36%1.23B |
| Financing cost | 35.02%-25.17M | 18.01%-66.9M | -77.67%-38.74M | -35.47%-81.6M | 32.63%-21.8M | 66.77%-60.23M | 74.53%-32.36M | 35.45%-181.27M | 7.91%-127.05M | -13.75%-280.84M |
| Share of profits of associates | -211.52%-184K | 175.66%143K | --165K | ---189K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -185.71%-314.61M | -526.86%-223.66M | -148.64%-110.12M |
| Earning before tax | 17.96%1.9B | 66.64%3.34B | 94.95%1.61B | 66.86%2.01B | 14.50%826.95M | 36.30%1.2B | 121.61%722.2M | 4.83%882.33M | -3.22%325.9M | 6.02%841.65M |
| Tax | -25.25%-410.71M | -51.10%-643.3M | -66.09%-327.92M | -99.82%-425.74M | -102.32%-197.44M | -17.44%-213.06M | 20.70%-97.59M | 9.24%-181.42M | -201.34%-123.06M | -80.16%-199.89M |
| After-tax profit from continuing operations | 16.10%1.49B | 70.83%2.7B | 104.00%1.28B | 59.77%1.58B | 0.78%629.52M | 41.18%989.59M | 207.94%624.62M | 9.22%700.92M | -31.46%202.84M | -6.03%641.76M |
| Earning after tax | 16.10%1.49B | 70.83%2.7B | 104.00%1.28B | 59.77%1.58B | 0.78%629.52M | 41.18%989.59M | 207.94%624.62M | 9.22%700.92M | -31.46%202.84M | -6.03%641.76M |
| Minority profit | -59.77%-409K | -611.27%-505K | ---256K | -104.77%-71K | ---- | 171.80%1.49M | --1.54M | ---2.07M | ---- | ---- |
| Profit attributable to shareholders | 16.11%1.49B | 70.85%2.7B | 104.04%1.28B | 60.01%1.58B | 1.03%629.52M | 40.56%988.1M | 207.18%623.08M | 9.54%702.99M | -31.46%202.84M | -6.03%641.76M |
| Basic earnings per share | 16.11%0.8208 | 71.10%1.4867 | 104.60%0.7069 | 61.81%0.8689 | 2.04%0.3455 | 34.89%0.537 | 182.87%0.3386 | 1.71%0.3981 | -33.68%0.1197 | -6.36%0.3914 |
| Diluted earnings per share | 1.71%0.3981 | -33.68%0.1197 | 21.29%0.3914 | |||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data